M
oyamoya disease is a rare cerebrovascular disorder of uncertain cause. It is characterized by progressive occlusion of the supraclinoid internal carotid artery and other vessels comprising the circle of Willis, resulting in formation of collaterals that have a cloudy appearance on angiography. Until recently, the disease was diagnosed primarily in Asia (4) . It appears to have a bimodal age of onset, with diagnosis in the first or the third and fourth decades of life (26) . Neuropsychological sequelae have been described and can be profound, at least with regard to intelligence in children (19, 25) . However, research on cognitive effects of the disorder has been limited in scope and generalizability. Almost all research has included only intelligence testing. Most of the literature has originated in Japan and has primarily focused on pediatric cases. Many studies assess mental ability only after neurosurgical intervention.
Despite some early interest (11) , there has been little neuropsychological research on moyamoya disease in adults. The adult literature is composed of five case studies (3, 11, 14, 18, 21) . The results of presurgical neuropsychological testing in these cases indicate that impairment in intellect (18) , speed of information processing (3), executive functioning (18) , and visual spatial ability (11, 14, 21) can occur. In this small series of cases, the most consistent finding was relatively intact memory functioning (3, 18, 21) . The only exception involved a case of right hemisphere infarction, resulting in impaired nonverbal memory (14) .
Unfortunately, the characteristics of these case study patients make it difficult to deter-
Data Analysis
Most raw cognitive test scores were converted to demographically adjusted (age, education, and sex) t scores using published normative data (10) . These scores were then converted to z scores. Exceptions were the California Verbal Learning Test II, Wechsler Memory TestRevised Visual Reproduction, and Delis-Kaplan Executive Function System Design Fluency Test. For these measures, age-adjusted z score equivalents were obtained following manual procedures. For all cognitive tests, z scores of 1 SD below the normative mean were considered to indicate impairment. For each test, the percentage of subjects with test performances more than 1 SD below the mean was calculated. Finally, the number of subjects with sufficiently poor overall performance to be characterized as cognitively impaired was calculated (9) . This was defined as having, on average, at least half of a patient's test scores rated as at least mildly impaired (mild impairment was defined as 1-2 SDs below the mean). Moderate to severe impairment was defined as having, on average, at least half of a patient's scores at least moderately impaired (moderate impairment was defined as 2-3 SDs below the mean, and severe impairment was defined as Ն3 SDs below the mean).
A BDI-II score of 14 or greater was the criterion for the presence of depression (1) . The number of subjects at each level of depression severity was tabulated.
RESULTS
The mean z scores for each clinical variable are presented in Table 1 . None of the mean z scores were in the impaired range, indicating that, on average, performances were within normal limits for all measures given. The lowest scores were for Trail Making Test Forms A and B, FAS, AN, and Grooved Pegboard Test-Dominant and Nondominant Hands. The highest scores represented memory and vocabulary ability.
The percentage of subjects with scores in the impaired range for each measure is also shown in Cognitive impairment was present in 11 (31%) of the patients. This was judged to be moderate to severe in four patients (11%).
The mean score on the BDI-II was within normal limits (mean ϭ 10.1, SD ϭ 5.4). Only seven of the subjects obtained scores in the clinical range. Five of these subjects reported a mild level of depression, and two reported a moderate level.
DISCUSSION
This is the first study to evaluate the effect of moyamoya disease on cognition in a large series of adults. Previous research has been limited to several case studies. The present findings suggest that moyamoya disease diagnosed in adults has significant impact on cognition but that this effect is not severe or pervasive. On measures of intelligence and other cognitive abilities, mine the pattern of ability strengths and weaknesses in moyamoya disease, per se. Three of the patients (and questionably a fourth) had an infarction in the right hemisphere before neuropsychological testing (3, 11, 14, 21) . The fifth patient had a diagnosis of schizophrenia and was actively psychotic when evaluated (18) . The occurrence of a major cerebral infarction before neuropsychological testing raises a significant conceptual issue when attempting to understand the cognitive effects of moyamoya disease itself; the fundamental pathology may well be that of microvascular ischemia, but some patients do experience one or more major cerebral infarctions or hemorrhages. If major stroke is judged a separate entity, it is questionable whether the previous case studies should be considered as evidence for the effects of moyamoya disease on cognition. Previous case studies are also problematic because they varied substantially in the cognitive abilities assessed and in the tests used to evaluate these abilities. In some instances, a limited range of abilities was assessed.
The current study sought to more comprehensively document the nature of cognitive impairment in moyamoya disease by evaluating a large number of adult patients with a neuropsychological test battery.
PATIENTS AND METHODS

Patients
Between October 2004 and December 2006, 36 adult patients with neurodiagnostically confirmed moyamoya disease underwent presurgical neuropsychological assessment. A protocol reviewed and approved by the medical center's institutional review board was used. All subjects were proficient in English (Wechsler Adult Intelligence Scale III Vocabulary age scale score of Ն8). The average age was 36.6 years (standard deviation [SD] ϭ 9.9). Mean education was 14.2 years (SD ϭ 1.8 years). Twenty-four subjects were female, and 34 subjects were right-handed. Ethnicities were white (27) , Asian (6), and AfricanAmerican (3). Twenty-five subjects were in full-time paid employment. There were also five homemakers, five unemployed persons, and one retired person.
Neuropsychological Assessment
Intelligence was evaluated with the Wechsler Adult Intelligence Scale-Third Edition (27) . Memory was assessed with the California Verbal Learning Test-II (6) and the Wechsler Memory Test-Revised Visual Reproduction subtest (28) . A number of executive functioning tests were also administered to the subjects. These were the DelisKaplan Executive Function System Design Fluency Test (5), Letter and Category Fluency Tests (FAS and AN) (8) , and the Trail Making Test Part B (24) . Sensorimotor function was assessed with Grooved Pegboard (23) and the Tactile Form Recognition Test (24) . Expressive language was measured with the Boston Naming Test (15) , and speed of processing was measured with the Trail Making Test Part A (24). The Beck Depression Inventory (BDI)-II (1) was used as a self-report measure of depression.
The neuropsychological tests were administered to all subjects in accord with manual instructions. Subjects were evaluated in a single 3-hour session. Five subjects were not given the Tactile Form Recognition Test, and one subject did not take the BDI-II.
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mean performance was within normal limits on all tests given. Mean Full Scale Intelligence Quotient (IQ) was 95. This is in contrast with the usual finding in pediatric moyamoya disease, in which significant loss of intellectual capacity is common. In a group of 104 pediatric cases, 38% had a Full Scale IQ or equivalent of less than 80 (12, 13, 19, 22, 25) . In contrast, 11% of the patients in the current study had a Full Scale IQ of less than 80, suggesting that with diagnosis in adulthood the effects of the disorder are generally milder than with early onset. This is reflected in the proportion (84%) of the current sample who were gainfully employed at the time of assessment. The finding of relative sparing of cognition in adult moyamoya disease has not been documented previously. The cause of this sparing is not known, but it may be related to a differential effect of the disease on the developing and mature nervous systems.
In general, intellectual functioning is less affected by neurological disorders than other aspects of cognition, such as memory and mental flexibility (16) . For this reason, understanding the effects of a neurological disorder on mental functioning requires comprehensive neuropsychological evaluation. Such an evaluation in the current study indicates that moyamoya disease, although not severe or generalized in its effects, does result in cognitive impairment in adults. This is most apparent in executive functioning. Approximately half of the patients in the current study had impairment in executive abilities, such as initiation and mental set-shifting efficiency. In the three previous case studies in which executive functioning was measured (3, 14, 18) , impairment was found on some measures but not others. The consistent impairment of executive abilities in the current study raises the possibility that adult moyamoya disease affects frontal lobe function.
Deterioration in memory capacity has been identified as one of the most frequent effects of damage to the brain in general (17) . This highlights the striking lack of memory impairment in the present study. This sparing is consistent with the results from previous research on moyamoya disease, which rarely indicates memory impairment (3, 18, 21) . Together, these results suggest that the medial temporal area of the brain and associated structures subserving memory function tend to be spared by moyamoya neuropathology. This may reflect the geographic distribution of the vascular pathology underlying moyamoya disease.
The prevalence of depression after the onset of discrete neurological events such as stroke or head injury is high: 20 to 40% (20) . However, moyamoya disease is usually not a discrete event, but rather a subacute or chronic disorder with gradual or stepwise progression. Therefore, a reasonable analog group might be patients with epilepsy who are awaiting surgical intervention. Moderate to severe depression on the BDI has been reported in 22% of such a group (7). The low rate (5%) of substantial depression in our patients with moyamoya disease was unexpected. A number of differences between the two groups might account for the different rates of depression. The patients with moyamoya disease seemed to perceive the disease as having modest impact on their activities and abilities, and there was a comparatively short latency between diagnosis and surgical intervention (median, 3 mo). In contrast, patients with epilepsy typically have substantial psychosocial and activities of daily living losses (e.g., loss of driving privilege). They also have a lengthy experience of failed medication trials before surgical treatment is considered, with an average latency from onset to surgical evaluation of 9 years in one study (2) . The perceived lack of impact of moyamoya disorder on quality of life will be addressed in a future study. The incidence of discrete cerebrovascular events in the current sample is unknown. Thus, the proportion of neuropsychological impairment that can be attributed to moyamoya disease itself, as opposed to secondary ischemia or hemorrhage, is also unknown. In previous adult case studies, some form of stroke had occurred in most of the patients before assessment, and the cognitive impairment found in these studies may have resulted from stroke, rather than moyamoya disease. Separation of these factors would be an important goal for future studies and is anticipated in a future article by our group.
CONCLUSION
The current study is the first systematic and comprehensive examination of the cognitive effects of moyamoya disease in adults. Pediatric research suggests substantial and pervasive impairment in mental functioning. In contrast, the current results indicate clear but selective impact on cognition in adults, with many ability domains spared and several clearly affected. The pattern of results also suggests brain regionbehavior correlations that deserve further exploration.
